Stille AB

Stockholm Stock Exchange STIL.ST

Stille AB Revenue for the year ending December 31, 2023: USD 29.11 M

Stille AB Revenue is USD 29.11 M for the year ending December 31, 2023, a 23.72% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.
  • Stille AB Revenue for the year ending December 31, 2022 was USD 23.53 M, a 14.22% change year over year.
  • Stille AB Revenue for the year ending December 31, 2021 was USD 20.60 M, a 19.16% change year over year.
  • Stille AB Revenue for the year ending December 31, 2020 was USD 17.29 M, a 3.70% change year over year.
  • Stille AB Revenue for the year ending December 31, 2019 was USD 16.67 M, a 9.12% change year over year.
Key data
Date Revenue Gross Profit Operating Income EBIT
Market news
Loading...
Stockholm Stock Exchange: STIL.ST

Stille AB

CEO Mr. Torbjorn Skold
IPO Date Nov. 29, 2005
Location Sweden
Headquarters Ekbacken 11
Employees 151
Sector Health Care
Industries
Description

Stille AB develops, manufactures, and sells surgical instruments in Sweden and internationally. It offers artery forceps and ligature clamps; bone cutters and rongeurs; clamps, curettes, raspatories, elevators, forceps, and micro instruments; needle holders, and wire twisting and holding forceps; and osteotomes, chisels, retractors and skin hooks, scissors, and other products, as well as c-arm tables. The company also provides ERCP/abdominal fluoroscopy, neuro/spine, pain management, urology, and vascular surgeries. In addition, it provides instrument repair, maintenance, and inspection services. Further, the company's products are used in various open surgeries. It has a collaboration agreement with GE Healthcare and distribution agreement with Synovis Micro. The company sells through OEM manufacturers of C-frames, distributors, and direct sales. The company was founded in 1841 and is headquartered in Torshälla, Sweden. Stille AB is a subsidiary of Linc AB.

Similar companies

CRAD-B.ST

C-Rad AB (publ)

USD 2.57

-0.02%

GENO.ST

Genovis AB (publ.)

USD 2.09

-2.04%

BOUL.ST

Boule Diagnostics AB (publ)

USD 0.89

14.73%

CEVI.ST

CellaVision AB (publ)

USD 18.76

3.89%

StockViz Staff

January 15, 2025

Any question? Send us an email